HUBER+SUHNER has developed the SENCITY® Road MULTI antenna, the latest addition that completes the SENCITY® Road product family. It enables multiple on-board applications to be hosted in one single antenna. It is designed for commercial vehicles, such as buses, trucks, ambulance cars, forest harvesters, agricultural vehicles and more. Rising data demands are being seen more… Read More »
Dedicated antennas optimised for light rail vehicles have been launched by HUBER+SUHNER, further expanding its offering to the transport sector. As all transportation market segments look to cope with rising bandwidth demand, rail, light rail, and road vehicles all have different requirements. The SENCITY® Tram rooftop antennas range has been developed to provide an all-in-one… Read More »
He said New York has more than 25,000 coronavirus cases — at least 10 times as many as any other state — and his state needs 30,000 more ventilators on top of the 7,000 it has. Cuomo wants all of what he called a current federal stockpile of 20,000 ventilators to brace for the coming… Read More »
MÁLAGA, SPAIN – SEPTEMBER 22: British citizens came from different places of Costa del Sol … [+] demonstrate against Brexit and Prime Minister Boris Jonhson on September 22, 2019 in Málaga, Spain. (Photo by Álex Zea/Europa Press via Getty Images) (Photo by Europa Press News/Europa Press via Getty Images) Europa Press via Getty Images Spain… Read More »
Supporters react as US presidential candidate Bernie Sanders arrives with his wife Jane for a rally at the Pasadena Convention Center in Pasadena, California on May 31, 2019. (Photo by Frederic J. BROWN / AFP) Getty At a climate-themed CNN ‘town hall’ event on Wednesday, Democratic presidential hopeful Sen. Bernie Sanders made comments that have… Read More »
Opdivo, the blockbuster cancer drug Bristol-Myers Squibb co-developed with Japan’s Ono Pharmaceutical, is a cash cow in the global market. But a Nobel laureate who helped create the drug isn’t happy with his cut. Tasuku Honjo, a Japanese immunologist and Nobel Prize winner for his identification of the immune cell protein PD-1, wants to renegotiate… Read More »